Deleted Tweets From Scott Gottlieb, R-D.C.

2/2 #FDA evaluated 3 bulk drug substances that were nominated for outsourcing facilities to use in compounding. In our preliminary assessment, we don’t see a clinical need for outsourcing facilities to compound these bulk substances. More info: https://t.co/Pc9Iiis709

1/2 #FDA knows that compounded drug products can serve an important medical need for patients, but these products don’t meet the same standards as FDA-approved drugs. Our action today is an important step to protect public health https://t.co/Pc9Iiis709

RT @RAPSorg: .@US_FDA Singles Out Three Drug Substances to Not be Compounded | #Regulatory Focus https://t.co/vfRhqtue6D #FDA #pharma #drugcompounding

RT @FDA_ORA: How much do you know about the organisms that cause foodborne illness? FDA has more info on the foodborne disease-c… https://t.co/knLXSZvqlD

RT @FDATobacco: Between 2014-16, FDA’s “The Real Cost” campaign prevented 350K youth aged 11-18 from trying cigarettes – about half… https://t.co/dpuf1lEpYn

RT @FDAOncology: How is FDA approaching the use of patient-reported outcomes in regulatory decision making? Hear directly from Dr. P… https://t.co/A737GlHSXB

RT @GaviSeth: Measles cases in Europe this year have already exceeded the number of cases seen annually in each of the last five… https://t.co/1MlPtLHl4l

2/5 #FDA is currently testing and analyzing product samples collected at the facility. Several microbial contaminants were found in its products, including a strain of bacteria called Burkholderia cepacia complex that can cause illness in people with compromised immune systems.

1/5 King Bio is expanding their recall of hundreds of Dr. King’s homeopathic products due to microbial contamination, including products for adults, children and pets. More info: https://t.co/J0QHN66zds

5/5 We respect that people may choose to use homeopathic products, but #FDA has a responsibility to protect the public from products that may not deliver any benefit and have the potential to cause harm. Our new policy can be found here: https://t.co/bOfLo1eKjW

4/5 We’ve seen a large uptick in homeopathic products marketed for a wide array of diseases and conditions. Our approach to regulating homeopathic drugs is evolving to reflect current complexity of the market, which is why we’re taking a more risk-based approach to enforcement

3/5 While the King Bio homeopathic products recalled are due to a microbial contamination issue, products labeled as homeopathic have not been reviewed by the FDA for safety and effectiveness

RT @SecAzar: As we combat the opioid crisis, we can't forget that pain is a real challenge for millions of Americans in every co… https://t.co/FjBgHZs7hd

#FDA took action today against 21 websites marketing unapproved opioids as part of agency’s effort to target illegal online sales. This brings to 70 the number of websites we’ve taken action against this summer for marketing unapproved opioids: https://t.co/qcirvFlDpk.

RT @FDATobacco: This summer marks one year since Commissioner @SGottliebFDA announced FDA’s Comprehensive Plan for Tobacco and Nico… https://t.co/ZlBKSGnqEh

#FDA is working with drug manufacturers to ensure future valsartan active pharmaceutical ingredients are not at risk of NDMA formation. #FDA has valsartan recall information from several companies on our website; we’ll continue to provide updates. https://t.co/W7RZc7h1Qk

Today, #FDA took another action in the fight against the illegal sale of opioids online by issuing warning letters to online networks operating 21 websites. https://t.co/Y9vYrU1p1d

Today’s batch of warning letters to illegal online pharmacies selling opioids follows the June summit #FDA hosted with key stakeholders to discuss ways to collaborate to reduce the availability of illicit opioids online. https://t.co/Y9vYrU1p1d

#FDA cannot allow the illegal online sale of opioids to fuel the opioid crisis and will continue to pursue all means of enforcement to hinder online drug dealers and curb this dangerous practice. https://t.co/Y9vYrU1p1d

It brings to 70 the number of actions we’ve taken against websites this summer to address the marketing of unapproved opioid drugs.

2/2 #FDA evaluated 3 bulk drug substances that were nominated for outsourcing facilities to use in compounding. In our preliminary assessment, we don’t see a clinical need for outsourcing facilities to compound these bulk substances. More info: https://t.co/Pc9Iiis709

1/2 #FDA knows that compounded drug products can serve an important medical need for patients, but these products don’t meet the same standards as FDA-approved drugs. Our action today is an important step to protect public health https://t.co/Pc9Iiis709

RT @RAPSorg: .@US_FDA Singles Out Three Drug Substances to Not be Compounded | #Regulatory Focus https://t.co/vfRhqtue6D #FDA #pharma #drugcompounding

RT @FDA_ORA: How much do you know about the organisms that cause foodborne illness? FDA has more info on the foodborne disease-c… https://t.co/knLXSZvqlD

RT @FDATobacco: Between 2014-16, FDA’s “The Real Cost” campaign prevented 350K youth aged 11-18 from trying cigarettes – about half… https://t.co/dpuf1lEpYn

RT @FDAOncology: How is FDA approaching the use of patient-reported outcomes in regulatory decision making? Hear directly from Dr. P… https://t.co/A737GlHSXB

RT @GaviSeth: Measles cases in Europe this year have already exceeded the number of cases seen annually in each of the last five… https://t.co/1MlPtLHl4l

2/5 #FDA is currently testing and analyzing product samples collected at the facility. Several microbial contaminants were found in its products, including a strain of bacteria called Burkholderia cepacia complex that can cause illness in people with compromised immune systems.

1/5 King Bio is expanding their recall of hundreds of Dr. King’s homeopathic products due to microbial contamination, including products for adults, children and pets. More info: https://t.co/J0QHN66zds

5/5 We respect that people may choose to use homeopathic products, but #FDA has a responsibility to protect the public from products that may not deliver any benefit and have the potential to cause harm. Our new policy can be found here: https://t.co/bOfLo1eKjW

4/5 We’ve seen a large uptick in homeopathic products marketed for a wide array of diseases and conditions. Our approach to regulating homeopathic drugs is evolving to reflect current complexity of the market, which is why we’re taking a more risk-based approach to enforcement

3/5 While the King Bio homeopathic products recalled are due to a microbial contamination issue, products labeled as homeopathic have not been reviewed by the FDA for safety and effectiveness

RT @SecAzar: As we combat the opioid crisis, we can't forget that pain is a real challenge for millions of Americans in every co… https://t.co/FjBgHZs7hd

#FDA took action today against 21 websites marketing unapproved opioids as part of agency’s effort to target illegal online sales. This brings to 70 the number of websites we’ve taken action against this summer for marketing unapproved opioids: https://t.co/qcirvFlDpk.

RT @FDATobacco: This summer marks one year since Commissioner @SGottliebFDA announced FDA’s Comprehensive Plan for Tobacco and Nico… https://t.co/ZlBKSGnqEh

#FDA is working with drug manufacturers to ensure future valsartan active pharmaceutical ingredients are not at risk of NDMA formation. #FDA has valsartan recall information from several companies on our website; we’ll continue to provide updates. https://t.co/W7RZc7h1Qk

Today, #FDA took another action in the fight against the illegal sale of opioids online by issuing warning letters to online networks operating 21 websites. https://t.co/Y9vYrU1p1d

Today’s batch of warning letters to illegal online pharmacies selling opioids follows the June summit #FDA hosted with key stakeholders to discuss ways to collaborate to reduce the availability of illicit opioids online. https://t.co/Y9vYrU1p1d

#FDA cannot allow the illegal online sale of opioids to fuel the opioid crisis and will continue to pursue all means of enforcement to hinder online drug dealers and curb this dangerous practice. https://t.co/Y9vYrU1p1d

It brings to 70 the number of actions we’ve taken against websites this summer to address the marketing of unapproved opioid drugs.